2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$23.50-$0.005 (-0.02%)
Price as of Oct 22, 2026 7:30 PM EDT- $746.0MMarket Cap
- -33.88%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$23.50-$0.005 (-0.02%)
COLL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.50 | ||
Change | -$0.32 (-1.36%) | ||
Open | $23.03 | ||
High | $23.84 | ||
Low | $22.94 | ||
Previous Close | $22.91 | ||
Volume | 738,765 | ||
30-Day Average Volume | 736,253 | ||
1-Week Change | 1.80% | ||
1-Month Change | -0.54% | ||
1-Year Change | -35.83% | ||
3-Year Change | 6.73% | ||
5-Year Change | 8.86% | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $2.1B | ||
Market Cap | $746.0M | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $199.9M | ||
Net Income | -$15.1M | ||
Free Cash Flow | $70.8M | ||
EBIT | -$517,000.00 | ||
EBITDA | $62.4M | ||
Net Working Capital | $18.2M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 2 | ||
P/E | -50 | ||
PEG | 0 | ||
Price/Free Cash Flow | 11 | ||
Price/Operating Cash Flow | 10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue